Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	219.00M -0.2%
Revenue (ttm)	336.68M -1.4%
Net Income	5.02M -51.6%
EPS	0.06 -53.0%
Shares Out	81.41M
PE Ratio	44.83
Forward PE	38.43
Dividend	0.05 (1.84%)
Ex-Dividend Date	May 15, 2025

Volume	13,184
Average Volume	12,642
Open	2.710
Previous Close	2.690
Day's Range	2.710 - 2.740
52-Week Range	2.320 - 3.400
Beta	0.90
RSI	61.79
Earnings Date	May 7, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the For...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,512
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2025, Laboratorio Reig Jofre's revenue was 336.68 million, a decrease of -1.37% compared to the previous year's 341.37 million. Earnings were 5.02 million, a decrease of -51.64%.